HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New-generation multifocal intraocular lens for pediatric cataract.

AbstractBACKGROUND/AIMS:
To evaluate multifocal intraocular lens (MIOL) implantation in children.
METHODS:
This is a retrospective study evaluating refractive, visual and safety results of MIOL in pediatric cataract surgery. Average follow-up was 25.73 ± 10.5 months. Surgery included 12 o'clock clear corneal incision, anterior capsulorhexis, lens material aspiration and MIOL implantation (SN6AD3; Alcon).
RESULTS:
We included 34 cataract eyes of 26 pediatric patients aged 2-15 years, of which 14 (54%) were unilateral. Best near visual acuity (BNVA) and best distance visual acuity (BDVA) improved significantly in 100% of eyes (p = 0.0001). BDVA was above 0.8 in 31.25% (5/16) of bilateral cases. Significant stereopsis improvement was observed postoperatively in bilateral cases only (p = 0.01).
CONCLUSION:
MIOL implantation is a safe alternative to monofocal pseudophakia for pediatric cataract with a very low complication rate. Significant BNVA, BDVA and stereopsis improvement can be achieved, particularly in bilateral cases.
MESSAGE:
This study shows significant BDVA, BNVA and stereopsis improvement, especially in bilateral cases, after MIOL implantation for pediatric cataracts.
AuthorsHana Abouzeid, Leila Moetteli, Francis L Munier
JournalOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (Ophthalmologica) Vol. 230 Issue 2 Pg. 100-7 ( 2013) ISSN: 1423-0267 [Electronic] Switzerland
PMID23880970 (Publication Type: Journal Article)
Copyright© 2013 S. Karger AG, Basel.
Topics
  • Adolescent
  • Cataract (congenital)
  • Cataract Extraction
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Lens Implantation, Intraocular
  • Lenses, Intraocular
  • Male
  • Prosthesis Design
  • Retrospective Studies
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: